Search results
May 19, 2021 · As with all sarcomas, the treatment plan for synovial sarcoma is individualized to each patient. Both patient and tumor variables are taken into account in a multidisciplinary setting to determine the ideal treatment strategy for each patient.
- Aaron M. Gazendam, Snezana Popovic, Sohaib Munir, Naveen Parasu, David Wilson, Michelle Ghert
- 10.3390/curroncol28030177
- 2021
- Curr Oncol. 2021 Jun; 28(3): 1909-1920.
Mar 7, 2018 · Synovial sarcoma (SS) is a rare, yet highly malignant, type of soft tissue sarcoma (STS), for which survival has not improved significantly during the past years. In this review, we focus on systemic treatment in adults. Compared to other STS, SS are relatively chemosensitive.
- Ingrid M. E. Desar, Emmy D. G. Fleuren, Winette T. A. van der Graaf
- 2018
May 6, 2023 · The treatment of patients with synovial sarcoma is based on the stage of presentation. A patient with SS can either present with localized or metastatic disease. Generally, a localized disease is approached to achieve a microscopic negative margin (R0 resection) surgically.
- Ankit Mangla, David P. Gasalberti
- 2023/05/06
Aug 23, 2023 · Treatment of synovial sarcoma in localized phase follows the usual rules of sarcoma treatment, with uncertainties on the value of systemic treatment. In advanced phase, the disease is rarely curable, with current systemic treatments.
Aug 29, 2017 · Synovial cell sarcoma is one of the most common soft-tissue tumors in adolescents and young patients, with approximately one third of cases occurring in the first two decades of life. Mean...
May 19, 2021 · Abstract. Synovial sarcomas (SS) represent a unique subset of soft tissue sarcomas (STS) and account for 5-10% of all STS. Synovial sarcoma differs from other STS by the relatively young age at diagnosis and clinical presentation.
People also ask
How common is synovial cell sarcoma?
What is a synovial sarcoma?
Who should be involved in the treatment of synovial sarcoma?
How is synovial sarcoma treated?
Dec 8, 2017 · Synovial sarcoma (SS) is a rare sarcoma driven by a translocation between SS18 and SSX 1, 2, or 4. With approximately 800 to 1,000 cases a year in the United States, it most commonly affects young adults between the ages of 15 and 30 years.
